Author

Stephen Ash

University of OxfordORCID 0000-0002-2970-3821Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

A. CarteriD· 1 shared Alistair EastoniD· 1 shared Andréa E. TijhuisiD· 1 shared Anna SchuhiD· 1 shared Anthony Cutts· 1 shared Antonio RuedaiD· 1 shared Arman ArdalaniD· 1 shared Benjamin IzariD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. CarterORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyScience AdvancesPeer-reviewedMar 11, 2026

Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis

Bruno Beernaert, Rose L. Jady‐Clark, Parin Shah…·Eileen E. Parkes

This study shows that chromosomal instability in esophageal adenocarcinoma drives an inflammatory tumor microenvironment through a cGAS-chemokine-myeloid axis, with CXCL8 as a key mediator.

11 citationstop 1%

humanspatial transcriptomics

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintSep 29, 2023

Multimodal cell-free DNA whole-genome analysis combined with TET-Assisted Pyridine Borane Sequencing is sensitive and reveals specific cancer signals

Dimitris V. Vavoulis, Anthony Cutts, Nishita Thota…·Anna Schuh

This paper develops a bioinformatics pipeline combining TAPS and whole-genome sequencing to detect ctDNA in cancer patients, achieving 85.2% sensitivity with 100% specificity.

1 citation

humanwhole-genome sequencing

𝕏 PostBluesky